Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1085-1089
Published online before print March 11, 2004, doi: 10.1161/01.STR.0000124927.38723.f2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/5/1085    most recent
01.STR.0000124927.38723.f2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Páramo, J.A.
Right arrow Articles by Diez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Páramo, J.A.
Right arrow Articles by Diez, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Carotid Artery Disease
Related Collections
Right arrow Thrombin
Right arrow Risk Factors
Right arrow Carotid Stenosis

(Stroke. 2004;35:1085.)
© 2004 American Heart Association, Inc.


Original Contributions

Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease

J.A. Páramo, MD, PhD; J. Orbe, PhD; O. Beloqui, MD, PhD; A. Benito, MD, PhD; I. Colina, MD, PhD; E. Martinez-Vila, MD, PhD J. Diez, MD, PhD

From Atherosclerosis Research (J.A.P., J.O.), Division of Cardiovascular Pathophysiology (J.A.P., J.O., J.D.), Internal Medicine (O.B., I.C.), Radiology (A.B.), and Neurology (E.M.-V.), University Clinic, School of Medicine, University of Navarra, Pamplona, Spain.

Correspondence to Dr José A. Páramo, Atherosclerosis Research, University Clinic, Avda Pio XII 36, 31008 Pamplona, Spain. E-mail japaramo{at}unav.es

Background and Purpose— Thrombin, a central enzyme in the clotting cascade, plays a role not only in thrombosis but also in the progression of atherosclerosis. We studied the relationship between prothrombin fragment 1+2 (F1+2), a specific marker of thrombin generation in vivo, and carotid intima-media thickness (IMT), an index of subclinical atherosclerosis.

Methods— We examined 181 asymptomatic middle-aged subjects (mean age 55.6 years, 76.7% men) free of overt clinical atherosclerotic disease. F1+2 was measured by enzyme-linked immunosorbent assay and IMT by duplex ultrasonography of carotid artery. Multiple linear regression analysis was used to assess the relationship between the 2 parameters.

Results— Compared with individuals in the lowest tertile of F1+2, those in the upper tertile (>0.55 nmol/L) showed significantly higher IMT (P<0.01). In correlation analysis, a positive relationship was found between plasma F1+2 and carotid IMT. F1+2 also correlated positively with cholesterol (P<0.008) and low-density lipoprotein cholesterol (P<0.005), but not with blood pressure or body mass index. In the multivariate analysis, the association of F1+2 with carotid IMT remained significant (P<0.001) after adjustment for age, sex, body mass index, systolic blood pressure, cholesterol, diabetes, and smoking.

Conclusions— In a population sample of adults without clinically overt atherosclerotic disease, the plasma levels of F1+2 were significantly associated with carotid IMT, suggesting a relationship between thrombin generation and the development atherosclerosis.


Key Words: prothrombin • atherosclerosis • carotid arteries • intima-media thickness • thrombin




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. M. Blanco-Colio, J. L. Martin-Ventura, B. Munoz-Garcia, J. Orbe, J. A. Paramo, J.-B. Michel, A. Ortiz, O. Meilhac, and J. Egido
Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 916 - 922.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Montero, J. Orbe, N. Varo, O. Beloqui, J. I. Monreal, J. A. Rodriguez, J. Diez, P. Libby, and J. A. Paramo
C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells: Implications for Clinical and Subclinical Atherosclerosis
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1369 - 1378.
[Abstract] [Full Text] [PDF]